Psychedelics

Kelsi Sheren said that other treatment methods for her PTSD and depression were ineffective

The study found that 100 per cent of patients were responsive and 92 per cent went into remission

The company focuses on developing novel psychoactive drugs with more gentle effects

It now has 19 million shares of the psychedelic drug developer, the firm's first investment in a public entity of this variety

The study findings represent the culmination of more than two decades of dedicated research efforts

Funds will be used to study psilocybin and MDMA-assisted therapy; non-profit says Sweden needs to 'catch up' in this area of research

Silo's SPC-15 was developed in collaboration with Columbia University

Lucy expects to complete the acquisition within 90 days

The paper in the journal Psychopharmacology concluded that a machine learning algorithm could predict treatment efficacy

Johns Hopkins University School of Medicine is the second U.S. clinical site to join Clearmind's trial, following Yale School of Medicine's psychiatry department

The MDMA producer is now trading under the symbol PMBHF, which is intended to attract more investors in the U.S.

Mindset shareholders will receive $0.75 in cash for each share, representing a premium based on various trading metrics

Silo Wellness will acquire all of NUGL's issued and outstanding shares in exchange for 2 million shares from its treasury

The companies say they will have the most substantial dataset on the DMT molecule in the industry and largest IP portfolio

The research could have far-reaching implications for the training of therapists and the delivery of psychedelic therapies in clinical settings

When ingested, 1,4-butanediol produces an effect that is not unlike that of Gamma-Hydroxybutyrate (GHB)

Poor mental health affects not only quality of life but performance, resilience and career trajectories of athletes

The clinical trials will examine the effects of the company's botanical psilocybin drug candidate PEX010

The model combines the use of a psychedelic medication with therapy in a single session

CYB003 is a molecule developed by the company with rapid onset and a short duration

The psychedelic drug developer says the new method increases potency while maintaining the mushroom's botanical qualities

The company announced the supply agreement last May

The majority of participants reported significant improvements in their overall mental health

The MHRA has confirmed that PharmAla's MDMA-like drug candidate ALA-002 does not require additional preclinical data

The transaction is expected to close in Q4 this year

The molecular structure of DMT is the backbone of some popular psychedelics being tested for medical purposes such as psilocin and LSD

The growth is attributed to a high number of clients at its psychedelic-assisted therapy clinics

Psychedelics help mitigate mental health issues in Veterans

The survey results follow the city of Berkeley decriminalizing psychedelic plants and fungi on Tuesday

The program is meant to offer and expand skillful and ethical lessons in the field of psychedelic therapeutics

Fund supporting the institution's Psychedelics and Health Research Initiative was provided by philanthropist Eugene Jhong

Amanita has a long history of use in religious and shamanic rituals in various cultures

'We have a big team behind us and we have a lot of people supporting us' said the store's co-owner on Thursday

Patients in Australia can use psilocybin and MDMA as of July 1

Filament will be licensing NeoLumina with its PEX010 drug and associated IP for commercial and clinical development

The rise in mental disorders and interest in psychedelic therapies contribute to the surge

Stella closed a US$7 million funding round led by Sterling Partners last month

It aims to highlight relevant considerations for researchers investigating the therapeutic value of psychedelics

HealingMaps was created to provide people with info about psychedelic therapy and help them find clinics

Upon completion of the program, participants will have the option to participate in two group psychedelic experiences